Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Presurgical models can effectively and affordably screen cancer prevention agents.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

A new treatment using dissolvable microneedles with nickel-copper and minoxidil improves hair growth and health in androgenetic alopecia.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Topical IKKα inhibitors may help prevent CCS tumours.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

5-ARI therapy may help prevent prostate cancer progression.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

MorrF improves hair growth better than minoxidil alone.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.